900 Participants Needed

Project nGage for HIV

(nGage Trial)

Recruiting at 6 trial locations
AB
DS
Overseen ByDavid S Batey, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to test a new approach to help people living with HIV stay in care and maintain low virus levels. The treatment, called Project nGage, involves support from a person in the participant's social network, such as a friend or family member, along with regular interactions with a case manager. The trial will compare this method to the usual HIV care. Ideal candidates are English-speaking adults aged 18-49 who have missed HIV care visits or have not recently controlled their virus, and who live in Chicagoland or Alabama. As an unphased trial, this study offers a unique opportunity to contribute to innovative HIV care strategies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the Project nGage intervention is safe?

Research has shown that Project nGage was tested in earlier studies. These studies examined how social networks can help people with HIV adhere to their treatment plans. The program includes selecting a support person, conducting face-to-face meetings, and providing regular follow-ups through text or phone calls.

Results from these studies have been mostly positive, indicating that Project nGage can help people attend appointments and take medication as prescribed. However, challenges have arisen, such as ensuring full participation in the program.

Regarding safety, Project nGage is a behavioral program, meaning it doesn't involve new drugs or medical procedures. This generally suggests it is well-tolerated. No solid evidence of harmful effects exists, and since it relies on support and communication, it is considered safe for participants.12345

Why are researchers excited about this trial?

Researchers are excited about Project nGage because it introduces a new approach to supporting people with HIV through social networks. Unlike standard treatments that mainly focus on medical care, Project nGage emphasizes the role of a Support Confidant to help patients stick to their treatment plans. This method involves interactive sessions that are personalized and can be delivered via text or phone, making it more flexible and accessible. By enhancing social support, the intervention aims to improve adherence to treatment and overall health outcomes, which could be a game-changer in managing HIV.

What evidence suggests that the Project nGage intervention is effective for promoting retention in care and viral suppression among people living with HIV?

Research has shown that Project nGage, which participants in this trial may receive, might help people with HIV remain engaged in their healthcare. A previous study found that using social networks can reduce risky behaviors related to HIV and increase HIV counseling and testing. Project nGage involves a trusted person in the participant's life to provide support. This method has shown promise in keeping young Black men who have sex with men involved in HIV care. By leveraging existing social support, Project nGage aims to improve health outcomes, such as maintaining viral control.16789

Who Is on the Research Team?

AB

Alida Bouris, PhD

Principal Investigator

University of Chicago

DS

David S Batey, PhD

Principal Investigator

Tulane University

Are You a Good Fit for This Trial?

This trial is for young Black sexual minority men aged 18-35 with HIV who speak English, own a personal cell phone, and have missed an HIV care visit in the past year. They must identify as cisgender men and agree to involve a non-romantic social support person in the intervention.

Inclusion Criteria

Own a cell phone not shared with anyone else
Have missed at least one HIV care scheduled visit in the past 12 months
I was born male and identify as a man.
See 3 more

Exclusion Criteria

If a participant fails to meet all inclusion criteria
Romantic/Sexual partners of Index Men
Relationship strain or abuse present in Index-SC relationship

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Project nGage intervention with selection and invitation of a Support Confidant (SC), a face-to-face session, and quarterly mini-booster sessions

12 months
1 in-person session, quarterly virtual sessions

Re-randomization and Continued Intervention

Participants re-randomized to continue receiving mini-boosters or return to treatment as usual

12 months
Quarterly virtual sessions for continued intervention group

Follow-up

Participants are monitored for retention in care and viral suppression

24 months

What Are the Treatments Tested in This Trial?

Interventions

  • Project nGage
Trial Overview Project nGage is being tested for its effectiveness in helping participants stay engaged in their HIV care and maintain viral suppression. It's a tailored approach that uses patients' social networks to support their treatment journey.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Social Network Support Intervention ConditionExperimental Treatment1 Intervention
Group II: Treatment as Usual ConditionActive Control1 Intervention

Project nGage is already approved in United States for the following indications:

🇺🇸
Approved in United States as Project nGage for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Chicago

Lead Sponsor

Trials
1,086
Recruited
844,000+

Thrive Alabama

Collaborator

Trials
1
Recruited
900+

Howard Brown Health

Collaborator

Trials
1
Recruited
900+

1917 Clinic at the University of Alabama at Birmingham

Collaborator

Trials
1
Recruited
900+

Tulane University

Collaborator

Trials
129
Recruited
259,000+

University of Alabama at Birmingham

Collaborator

Trials
1,677
Recruited
2,458,000+

Birmingham AIDS Outreach

Collaborator

Trials
3
Recruited
1,800+

Chicago Center for HIV Elimination

Collaborator

Trials
1
Recruited
900+

Published Research Related to This Trial

Project nGage, a randomized controlled trial involving 98 HIV-positive young black MSM, showed that engaging a support confidant significantly improved retention in HIV care, with participants being 3 times more likely to attend at least 3 provider visits over 12 months compared to the control group.
The intervention focused on enhancing HIV-care knowledge and social support, indicating that involving supportive network members can be an effective strategy to improve health outcomes in this population.
Project nGage: Results of a Randomized Controlled Trial of a Dyadic Network Support Intervention to Retain Young Black Men Who Have Sex With Men in HIV Care.Bouris, A., Jaffe, K., Eavou, R., et al.[2023]
The Positive Links smartphone app facilitated social support among 55 participants living with HIV over 8 months, with 52% of analyzed posts providing support, primarily emotional in nature.
Participants reported feeling a sense of connection and support through the app, although some faced technical issues that hindered their full engagement, highlighting the app's potential to improve care for those unable to access in-person support.
Social Support in a Virtual Community: Analysis of a Clinic-Affiliated Online Support Group for Persons Living with HIV/AIDS.Flickinger, TE., DeBolt, C., Waldman, AL., et al.[2018]
The PositiveLinks (PL) smartphone platform significantly improved engagement in care and HIV viral suppression among 127 participants over a 24-month period, with notable improvements seen as early as 6 months.
Patients who used PL more frequently were over twice as likely to achieve viral suppression and 1.5 times more likely to engage in care compared to those with lower usage, highlighting the effectiveness of mobile technology in managing HIV care.
Long term impact of PositiveLinks: Clinic-deployed mobile technology to improve engagement with HIV care.Canan, CE., Waselewski, ME., Waldman, ALD., et al.[2020]

Citations

Project nGage: Network Supported HIV Care Engagement for ...Pending study results, a larger RCT would compare the relative effectiveness of the Project nGage intervention versus TAU over 18 to 24 months. Keywords: HIV ...
Hybrid Type I Effectiveness-Implementation Trial of Project ...If effective, nGage has the potential to reduce HIV incidence by harnessing existing social support in the lives of people living with HIV ...
Hybrid Type I Effectiveness-Implementation Trial of a Social ...Project nGage: Results of a Randomized Controlled Trial of a Dyadic Network Support Intervention to Retain Young Black Men Who Have Sex With Men in HIV Care.
Project nGage: Results of a Randomized Controlled Trial ...Social network oriented interventions have been effective for preventing HIV-related risk behaviors (25, 26), and for increasing HIV counseling and testing ...
"Project nGage: Results of a Randomized Controlled Trial of a ...Project nGage was a randomized controlled trial conducted across five Chicago clinics with 98 HIV-positive YBMSM aged 16–29 between 2012 and ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/24404408/
Project nGage: Network Supported HIV Care Engagement ...Project nGage is a randomized controlled (RCT) trial evaluating the feasibility and preliminary efficacy of a brief, dyadic intervention designed to promote ...
Project nGage: Network Supported HIV Care Engagement ...The primary outcome is appointment attendance; the secondary outcomes are medication adherence and viral load. Implementation challenges include ...
The effect of a social network-based intervention to ...This study presents positive findings from a randomised controlled trial of a combined social network and HIV self-testing intervention to ...
Social network-based group intervention to promote HIV ...The primary outcomes are HIV testing and condom use among alter participants; secondary outcomes are engagement in HIV prevention advocacy and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security